Remove Biopharma Remove Manufacturing Remove Pharma Remove Pharmaceutical products
article thumbnail

Red Sea Shipping Disruptions Don’t Have Pharma Companies Seeing Red Just Yet

MedCity News

Generic drugs are the pharmaceutical products mainly affected by the missile attacks disrupting shipping in the Red Sea. While the extra costs borne by drug companies aren’t causing an immediate spike in product prices, experts say they’ll eventually be factored into prices if the attacks become a long-term problem.

article thumbnail

Pharma’s climate change vulnerability and opportunity

pharmaphorum

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth. Pharma’s reliance on global supply chains and its need for vast quantities of water make it particularly vulnerable to climate change. Responsibility .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Getting ahead of regulatory changes around PFAS in pharmaceutical packaging

Clarivate

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] However, this regulatory ban does not impact active pharmaceutical ingredients (APIs).

article thumbnail

Showing the value of regulatory intelligence in pharma [Podcast]

Clarivate

The pharmaceutical industry is among the most regulated of all commercial sectors. To be able to discover, develop, manufacture and sell medicines, pharmaceutical companies have to comply with masses of regulations, which despite efforts to find global standards, can still differ significantly between different markets.

Pharma 52